BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/23/2022 2:39:01 PM | Browse: 648 | Download: 2043
Publication Name World Journal of Hepatology
Manuscript ID 74769
Country United States
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Control Study
Article Title Clinical outcomes of coronavirus disease 2019 in liver transplant recipients
Manuscript Source Unsolicited Manuscript
All Author List Muhammad Shafiq and Cheryl Gibson
ORCID
Author(s) ORCID Number
Muhammad Shafiq http://orcid.org/0000-0002-0717-1764
Cheryl Gibson http://orcid.org/0000-0002-4025-8845
Funding Agency and Grant Number
Corresponding Author Muhammad Shafiq, MD, Assistant Professor, General and Geriatric Medicine, University of Kansas Medical Center, 4000 Cambridge Street, 6040 Delp & Mail Stop 1020, Kansas City, KS 66160, United States. mshafiq@kumc.edu
Key Words COVID-19; SARS-CoV-2; Liver transplant recipients; Clinical outcomes; Death; Hospitalization
Core Tip This was a case-control study that assessed the clinical outcomes of coronavirus disease 2019 (COVID-19) in liver transplant recipients. Our study did not show a significant difference in death or hospitalization rate due to COVID-19 between patients who had liver transplantation and those who did not. Our study also did not find any difference between these two groups in terms of duration of hospital stay, need for supplemental oxygen, presence of at least one type of end-organ damage, effect on liver enzymes, and d-dimer levels. Therefore, COVID-19 should not impact timely health care access and immunosuppression continuation among liver transplant recipients.
Publish Date 2022-06-23 14:39
Citation Shafiq M, Gibson C. Clinical outcomes of coronavirus disease 2019 in liver transplant recipients. World J Hepatol 2022; 14(6): 1142-1149
URL https://www.wjgnet.com/1948-5182/full/v14/i6/1142.htm
DOI https://dx.doi.org/10.4254/wjh.v14.i6.1142
Full Article (PDF) WJH-14-1142.pdf
Full Article (Word) WJH-14-1142.docx